| Schmitz, Joy |
NCT04843046: Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention |
|
|
| Recruiting | 2 | 60 | US | Cognitive Behavioral Therapy (CBT), CBT, Pioglitazone, Actos, Placebo, Corn Starch | The University of Texas Health Science Center, Houston, National Institute on Drug Abuse (NIDA) | Cocaine Use Disorder | 08/25 | 08/25 | | |
| Recruiting | N/A | 7500 | US | modafinil, Provigil, d-amphetamine, Dexedrine, L-Dopa, Sinemet, Naltrexone, Revia | The University of Texas Health Science Center, Houston, National Institute on Drug Abuse (NIDA) | Cocaine Abuse, Cocaine Dependence, Opiate Dependence, Alcohol Dependence, Substance Abuse | 06/26 | 06/26 | | |
| Vincent, Jessica |
NCT05711862: The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder |
|
|
| Terminated | 2 | 7 | US | SUVO, Placebo | The University of Texas Health Science Center, Houston | Methamphetamine Use Disorder | 03/24 | 03/24 | | |
| Completed | 2 | 14 | US | Suvorexant 20 mg, Suvorexant 0mg | The University of Texas Health Science Center, Houston | Smoking Cessation | 08/24 | 08/24 | | |
NCT06173778: Semaglutide for Post-Smoking Cessation Weight Management |
|
|
| Recruiting | 2 | 197 | US | semaglutide 2.4mg, Placebo, Nicotine Replacement Therapy (NRT, nicotine patch), Brief Smoking Cessation Counseling | The University of Texas Health Science Center, Houston | Obesity, Overweight, Cigarette Smoking | 07/26 | 08/26 | | |
NCT06444256: Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder |
|
|
| Recruiting | 2 | 20 | US | SUVO, TAU | The University of Texas Health Science Center, Houston | Stimulant Use Disorder | 06/25 | 06/25 | | |
| Not yet recruiting | 2 | 76 | US | Suvorexant, SUV, Dual orexin receptor antagonist, Placebo | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, University of California, Los Angeles, The University of Texas Health Science Center, Houston | Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia | 06/26 | 06/26 | | |
NCT05610800: Exenatide for Smoking Cessation and Prevention of Weight Gain |
|
|
| Recruiting | 2 | 216 | US | Exenatide 2 milligram (mg) Injection, Bydureon, Placebo, Nicotine patch, Smoking Cessation Counseling | The University of Texas Health Science Center, Houston | Smoking Cessation, Weight Gain | 03/26 | 05/26 | | |
NCT05107765: Effects of Pioglitazone on Stress Reactivity and Alcohol Craving |
|
|
| Recruiting | 1/2 | 60 | US | Pioglitazone, Placebo | The University of Texas Health Science Center, Houston, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder | 08/24 | 08/24 | | |
| Recruiting | 1 | 20 | US | Naltrexone (Vivitrol), Bupropion | The University of Texas Health Science Center, Houston | Smoking Cessation | 02/25 | 04/25 | | |
NCT06712446: A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder |
|
|
| Not yet recruiting | N/A | 20 | US | EFT, high frequency rTMS, sham frequency rTMS | The University of Texas Health Science Center, Houston | Methamphetamine Use Disorder | 12/25 | 12/25 | | |
NCT05986578: Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder |
|
|
| Recruiting | N/A | 75 | US | TMS to dmPFC, TMS to dlPFC, Sham iTBS | The University of Texas Health Science Center, Houston, National Institute on Drug Abuse (NIDA) | Cocaine Use Disorder | 06/28 | 06/28 | | |
